Related to JAK3
Advanced search
Search:  

1 - 10 of 15 results found for JAK3. Did you mean: jake

  1. Go6976 is a novel and potent inhibitor of JAK2 and JAK3 tyrosine kinases both in vitro...

    http://iris.ucl.ac.uk/iris/publication/155798/3

  2. Go6976, a novel and potent inhibitor of JAK2 and JAK3, reduces constitutive STAT activity...

    http://iris.ucl.ac.uk/iris/publication/155803/3

  3. The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents...

    http://iris.ucl.ac.uk/iris/publication/121152/1

  4. Malignancy risk associated with persistent HPV infection in gamma chain and JAK3 SCID...

    http://iris.ucl.ac.uk/iris/publication/1814761/1

  5. Unexpected and variable phenotypes in family with JAK3 deficiency

    http://iris.ucl.ac.uk/iris/publication/17795/1

  6. Unexpected Hypomorphic JAK3 Deficiency in a Child Presenting with Skin Granuloma and...

    http://iris.ucl.ac.uk/iris/publication/1018999/3

  7. JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute...

    http://iris.ucl.ac.uk/iris/publication/1694050/3

  8. Combined immunodeficiency due to JAK3 mutation in a child presenting with skin granuloma

    http://iris.ucl.ac.uk/iris/publication/1079150/3

  9. The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents...

    Extensive evidence suggests that the malignant cells of chronic lymphocytic leukemia (CLL) patients are in close contact with activated T lymphocytes, which secrete a range of cytoprotective cytokines including interleukin-4 (IL-4). IL-4 induced the

    http://iris.ucl.ac.uk/iris/publication/255095/2

  10. Rapid protein-based assays for the diagnosis of T-B+ severe combined immunodeficiency

    The severe combined immunodeficiencies (SCID) are a heterogeneous group of conditions arising from a variety of molecular defects. The X-linked form of SCID (X-SCID) is caused by defects in the common gamma chain (gammac), and is characterized by a T

    http://iris.ucl.ac.uk/iris/publication/17926/1

  11. Page: 1 2